Globus Medical director sells 25,000 shares at $87
GLOBUS MEDICAL INC (GMED) director Stephen T. Zarrilli reported an option exercise and same-day stock sale.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
GLOBUS MEDICAL INC (GMED) director Stephen T. Zarrilli reported an option exercise and same-day stock sale. He exercised 25,000 stock options for Class A Common Stock at an exercise price of $53.27 per share, then sold 25,000 shares of Class A Common Stock at a weighted average price of $87.0386 per share in multiple transactions. The options exercised were fully vested and, after the exercise, the reported option position in this grant was 0 shares.
Insider Trade Summary
Exercise and Sale: 25,000 shares ($844K approx. pre-tax spread)
Exercise and Sale
3 txns
Insider
ZARRILLI STEPHEN T
Role
Director
Sold
25,000 shs ($2.18M)
Approx. gross sale proceeds
$2.18M
Approx. exercise cost
$1.33M
Approx. pre-tax spread
$844K
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy Class A Common Stock) F2 | 25,000 | $0.00 | $0.00 |
| Exercise | Class A Common Stock | 25,000 | $53.27 | $1.33M |
| Sale | Class A Common Stock F1 | 25,000 | $87.0386 | $2.18M |
Holdings After Transaction:
Stock Option (Right to Buy Class A Common Stock) — 0 contracts (Direct);
Class A Common Stock — 0 shares (Direct)
Footnotes (2)
- F1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $86.92 to $87.16, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4.
- F2. These options were granted on January 22, 2020 and are fully vested.
Key Figures
Options exercised: 25,000 shares
Option exercise price: $53.27 per share
Shares sold: 25,000 shares
+5 more
8 metrics
Options exercised
25,000 shares
Stock Option (Right to Buy Class A Common Stock) exercised on 2026-08-18
Option exercise price
$53.27 per share
Conversion or exercise price for 25,000 underlying shares
Shares sold
25,000 shares
Class A Common Stock sale on 2026-08-18
Weighted average sale price
$87.0386 per share
Weighted average for multiple sale transactions, prices $86.92–$87.16
Sale price range
$86.92–$87.16 per share
Range of prices for the multiple sale transactions described in footnote (1)
Option grant date
January 22, 2020
Date the reported options were granted; they are now fully vested
Option expiration date
2030-01-22
Expiration date for the exercised stock options
Options remaining in this grant
0 shares
Total shares following option transaction for this grant
Key Terms
Stock Option (Right to Buy Class A Common Stock), Class A Common Stock, weighted average price, derivative security
4 terms
Stock Option (Right to Buy Class A Common Stock) financial
"security_title: Stock Option (Right to Buy Class A Common Stock)"
Class A Common Stock financial
"underlying_security_title: Class A Common Stock"
Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.
weighted average price financial
"The price reported in Column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
derivative security financial
"transaction_code_description: Exercise or conversion of derivative security"
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did GMED director Stephen T. Zarrilli report on this Form 4?
Stephen T. Zarrilli reported exercising 25,000 stock options for Globus Medical Class A Common Stock and selling 25,000 shares on the same day. The filing shows this as an option exercise followed by an open-market or private sale transaction.
What was the exercise price of the options exercised by GMED director Stephen T. Zarrilli?
The options exercised had an exercise price of $53.27 per share for 25,000 underlying shares of Class A Common Stock. These options were originally granted on January 22, 2020 and were fully vested at the time of the reported transaction.
Did Stephen T. Zarrilli retain any options from this specific Globus Medical grant after the transaction?
For this specific option grant, the reported balance after the transaction is 0 options remaining. The Form 4 lists the total shares following the option transaction as zero, indicating this particular grant was fully exercised according to the filing.
AI-generated analysis. How Rhea-AI works. Not financial advice.
